Skip to content

Effect of Oocyte Denudation Time and Intracytoplasmic Sperm Injection Time on Embryo Quality

The Effect of Oocyte Denudation Time and Intracytoplasmic Sperm Injection Time on Embryo Quality at Assisted Reproductive Technology Clinic

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05448859
Enrollment
200
Registered
2022-07-08
Start date
2017-01-01
Completion date
2019-12-31
Last updated
2022-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility Disorders

Keywords

infertility, assisted reproductive technology, embryo quality, oocyte denudation, intracytoplasmic sperm injection

Brief summary

An observational analytic retrospective study was conduct using cross-sectional study. The subject were oocytes from in-vitro fertilization procedures using the ICSI method at the assisted reproductive technology clinic in a private hospital in Bandung for the period 2017 - 2019. Three variables were oocyte denudation time, ICSI time and embryo quality collected from samples that met the research criteria.

Detailed description

This study analyses the different oocyte denudation time after ICSI on all embryos generated during IVF procedures between 1 Januaryr 2017 and 31 December 2019. All oocytes arer categorised on how many hours their denudation times were and these were then assessed for their qualities.

Interventions

PROCEDUREintracytoplasmic sperm injection

injection of sperm into an oocyte in assisted reproductive technology

Sponsors

Universitas Padjadjaran
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
3 Hours to 8 Hours
Healthy volunteers
No

Inclusion criteria

* oocytes collected from in-vitro fertilisation procedures involving intracytoplasmic sperm injection

Exclusion criteria

* oocytes from patients \>40 years old * oocytes from primary infertility \>5 years * endometriosis * polycystic ovarian syndrome

Design outcomes

Primary

MeasureTime frameDescription
Oocyte denudation time3 hourstime measured for oocyte denudation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026